| PERIOD ENDING | 31-Oct-09 | 31-Jul-09 | 30-Apr-09 | 31-Jan-09 | | Total Revenue | 14,866 | 14,788 | 14,845 | 15,856 | | Cost of Revenue | (5,464) | 5,464 | 4,945 | 5,944 | | | Gross Profit | 20,330 | 9,324 | 9,900 | 9,912 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 16,895 | 4,404 | 4,028 | 5,292 | | Non Recurring |
-
| 47,706 |
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,435 | (42,786) | 5,872 | 4,620 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 151 | 218 | (18) | 927 | | Earnings Before Interest And Taxes | 3,586 | (42,568) | 5,854 | 5,547 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 3,586 | (42,568) | 5,854 | 5,547 | | Income Tax Expense | 1,205 | (10,988) | 2,237 | 1,815 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,381 | (31,580) | 3,617 | 3,732 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,381 | (31,580) | 3,617 | 3,732 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,381 | ($31,580) | $3,617 | $3,732 |
|
0.09% Nasdaq 
0.13%
Income Statement
